BackPDL Biopharma Overview

PDL Biopharma Selling, General & Admin

Selling, General & Admin expenses for PDLI.

Quarterly SG&A Expenses

N/A

As of Sep 30, 2020

Annual SG&A Expenses (TTM)

$39.60M
18.08% YoY

Trailing 12 months ending Sep 30, 2020

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)